Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Clinical Pathology 2003;56:641-646; doi:10.1136/jcp.56.9.641
Copyright © 2003 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.
Journal of Clinical Pathology 2003;56:641-646
© 2003 BMJ Publishing Group Ltd. & Association of Clinical Pathologists

REVIEW

Best Practice No 173

Clinical and laboratory investigation of adult spontaneous hypoglycaemia

R Gama1, J D Teale2, V Marks3

1 Clinical Chemistry, New Cross Hospital, Wolverhampton, West Midlands WV10 0QP, UK
2 Clinical Pathology, Royal Surrey County Hospital, Guildford, Surrey GU2 7XX, UK
3 University of Surrey, Guildford, Surrey GU2 7XH, UK

Correspondence to:
Correspondence to:
Dr R Gama, Clinical Chemistry, New Cross Hospital, Wolverhampton, West Midlands WV10 0QP, UK;
dr.gama{at}rwh-tr.nhs.uk

ABSTRACT

Adult spontaneous hypoglycaemia is not a diagnosis per se but a manifestation of a disease. Although rare, it is important to identify spontaneous hypoglycaemia and its causes because treatment may be preventative or curative. Hypoglycaemia can occur as an epiphenomenon in many serious diseases. It is sufficient to recognise the disease’s association with hypoglycaemia and then take appropriate action to prevent the recurrence of hypoglycaemia. In investigating apparently healthy individuals, common pitfalls to avoid are: failure to recognise subacute neuroglycopenia clinically; failure to document hypoglycaemia adequately during symptoms; failure to measure pancreatic hormones, counter-regulatory hormones, and ketones in hypoglycaemic samples; failure to recognise pre-analytical and analytical limitations of laboratory assays; and failure to abandon obsolete and inappropriate investigations. Providing these caveats are met, appropriate laboratory and radiological investigations will almost always uncover the cause of spontaneous hypoglycaemia.

Keywords: hypoglycaemia; spontaneous; investigation, insulin; C peptide; review

Abbreviations: AIS, autoimmune insulin syndrome; ß-OHB, ß hydroxybutyrate; CSF, cerebrospinal fluid; GH, growth hormone; IGF, insulin-like growth factor; IR-A, anti-insulin receptor antibodies; IRI, immunoreactive insulin; NICTH, non-islet cell tumour hypoglycaemia


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • de Groot, J. W. B, Rikhof, B., van Doorn, J., Bilo, H. J G, Alleman, M. A, Honkoop, A. H, van der Graaf, W. T A (2007). Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases. Endocr Relat Cancer 14: 979-993 [Abstract] [Full Text]  
  • Halsall, D. J., Mangi, M., Soos, M., Fahie-Wilson, M. N., Wark, G., Mainwaring-Burton, R., O'Rahilly, S. (2007). Hypoglycemia due to an Insulin Binding Antibody in a Patient with an IgA-{kappa} Myeloma. J. Clin. Endocrinol. Metab. 92: 2013-2016 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs